PrimeRFP SCOUT · Federal Contract Recompete Brief

36C77022N0026REFILL of PHARM ITEMS to MEET — Neurocrine Biosciences, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Oct 22, 2021 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

National Cmop Office (36C770)

Awarding office

Neurocrine Biosciences, Inc

Recipient

Oct 22, 2021

PoP end

$678K

Obligated

$678K

Potential

325412

NAICS

6515

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Neurocrine Biosciences, Inc — $90

Contract facts

Federal

Contract number36C77022N0026

Also listed as36C770-22-N-0026

Also listed as36F79718D0414-36C77022N0026

AgencyNational Cmop Office (36C770)

Awarding officeNational Cmop Office (36C770)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentNeurocrine Biosciences, Inc

CAGE5H9C3

UEIGMQSH4CZ7EC9

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDV36F79718D0414

Place of performanceSAN DIEGO CA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startOct 15, 2021

PoP end (current)Oct 22, 2021

Obligated$678K

Current value$678K

Potential value$678K

REFILL OF PHARM ITEMS TO MEET CMOPS NEEDS is a federal award for National Cmop Office (36C770) held by Neurocrine Biosciences, Inc. Estimated value $678K ($678K obligated). Current period of performance ends Oct 22, 2021. Last award drew 1 bidder. Place of performance: SAN DIEGO CA.

REFILL OF PHARM ITEMS TO MEET CMOPS NEEDS

Recompete timing

Public

● Past PoP end (1764 days ago)

Current PoP ended Oct 22, 2021 (1764 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C77022N0026?

36C77022N0026 (REFILL of PHARM ITEMS to MEET) is a National Cmop Office (36C770) award with a potential value of $678K, currently held by Neurocrine Biosciences, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C770-22-N-0026?

36C770-22-N-0026 is the dashed form of PIID 36C77022N0026 (REFILL of PHARM ITEMS to MEET), held by Neurocrine Biosciences, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C77022N0026?

National Cmop Office (36C770) awarded 36C77022N0026 to Neurocrine Biosciences, Inc (potential $678K).

Who is the incumbent on 36C77022N0026?

Neurocrine Biosciences, Inc is the incumbent. The current period of performance ends Oct 22, 2021.

When does Neurocrine Biosciences, Inc’s 36C77022N0026 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 22, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Oct 19, 2021 · refreshed monthly